Avoiding Aldosterone Breakthrough in Hypertensive Diabetics: Role of Azelnidipine
Azelnidipine may contribute to avoid the "aldosterone breakthrough" by its suppressive effects on aldosterone synthesis and secretion
Hypertensive patients with type 2 diabetes carry a high cardiovascular risk. Most patients with hypertension and diabetes face higher mortality due to Heart disease and stroke. Hypertension also markedly increases the macrovascular complications like nephropathy and retinopathy in diabetic patients.
The above article has been published by Medical Dialogues under the MD Brand Connect Initiative. For more details on Azelnidipine, click here